NEW YORK — New medical devices are being developed to help people with spiral tube and heart attack sufferers.
They include a device that allows patients to pump their own blood to the tubes to relieve the pressure, a device to attach a tube to a chest tube and a new device that uses a pressure gauge that helps the operator determine how much blood is being pumped.
Dr. David Parets of the University of North Carolina at Chapel Hill and colleagues at the University at Buffalo have developed the new device, which is similar to the kind of pressure gauges used in the medical equipment industry.
It is also much simpler and cheaper than the traditional tubes and pressure gauging devices, the researchers said.
The device is called the Spiral Tube Oxygenation System.
It uses a thin sheet of plastic, called an Oxygen Tube, which comes in a variety of shapes and sizes to fit different patients.
It has a built-in microprocessor that uses ultrasound waves to measure oxygenation in the blood.
If the oxygenation level is high enough, the oxygen is pumped into the tube and the patient is taken to the hospital.
The Oxygen Gauge works similar to an oxygen saturation gauge that is used to measure blood pressure in hospitals.
Parett said the new devices also are much more accurate than the standard oxygen saturation gauges, which are used in most hospitals.
The Oxygen gauge is designed to be inserted into the tubes of a person with a heart attack, he said.
Parets said the device is being developed for patients who are at higher risk for having a heart failure because of heart failure or because of high blood pressure, such as people who have diabetes or high cholesterol.
It is not known how long the device would last, but the researchers are confident it will work well in people with heart failure.
“We believe that this device will provide a much safer, more reliable alternative to conventional oxygenation and pulse devices in the future,” he said in a statement.
Perets said this device is not new, but is an improvement.
The old devices, like the pressure gauge, used tubes that were too long to fit inside the patient, and often failed.
“It would just make the patient feel worse and worse,” Pareets said.
“If we can make the tube longer, the tube can move into the right place,” he added.
Paringts said that in patients who have already had a heart transplant, he would like to see more people use the Oxygen tube, even though the device will not help everyone.
“If you have a heart, we need to do everything we can to help you, but there is a limited number of patients who we can treat,” he explained.
The new device was also tested in a group of people who had heart attacks but who were still alive.
They had a tube inserted into a tube that was still too long for them, so the tube was inserted into another tube that they had already had inserted.
For a heart patient who had a stroke, the device did not work well.
The device did have some success in some people who are already in good physical health, but Paret said there was not a clear advantage to using the device.
He said the technology is still a ways from being able to help everyone, and is only going to be useful to people who already have heart attacks.
The technology is only available now for people who need it, and only for a small number of people, Paretz said.
It’s not yet clear how many people will be able to use the device in the near future.
The technology is being tested in the U.S., but Paringts expects it will be available in other countries as well.
